About this trial
Low back pain is a very common health problem in societies, regardless of the underlying cause. Its lifetime prevalence has been reported to be as high as 75-80%. Low back pain negatively affects the quality of life of affected individuals. In addition to diagnostic and treatment costs, it can lead to serious physical disability, resulting in loss of workforce and placing a substantial economic burden on countries. Many different factors play a role in the etiology of low back pain. According to etiology, it can be classified as idiopathic, mechanical, rheumatologic, metabolic, endocrine, infectious, neoplastic, neurologic/psychiatric disorders, and pain of visceral origin. The treatment of low back pain can be classified into medical treatment, physical therapy, percutaneous invasive interventions, and surgical intervention. TECAR therapy is also one of the treatment modalities routinely used in clinical practice. Our aim is to develop more effective physical therapy programs.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Having low back pain lasting longer than 12 weeks
Disqualifiers
None
Trial population
Patients presenting to the outpatient clinic of the Ankara Bilkent City Hospital Physical Therapy and Rehabilitation Hospital.
Trial design
Case-control
Prospective
Treatments tested in this trial
TECAR THERAPY
DeviceTECAR therapy applied by a technician for 20 minutes per session, three days per week, for a total of six sessions
TECAR Therapy
DeviceTECAR therapy is a new and effective treatment modality.
Treatment groups
Trial outcomes
Primary outcomes
Visual Analog Scale (VAS)
Zero indicates no pain at all, whereas ten represents the most severe pain imaginable.
Secondary outcomes
Oswestry Disability Index
The Oswestry Disability Index (ODI) is a standardized questionnaire designed to assess the degree of disability and functional impairment in individuals with lower back pain
Sponsors and contacts
Click on the lead sponsor to view all of their trials.